← FDA DRUG APPROVALS

FDA ANDA · ANDA079138

ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE

Sponsor: HOSPIRA

APPLICATION
ANDA079138
TYPE
ANDA
ORIGINAL APPROVAL
2010-06-18
LATEST ACTION
2013-02-28
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATEDiscontinued
ARTICAINE HYDROCHLORIDE 4%, EPINEPHRINE BITARTRATE EQ 0.017MG BASE/1.7ML (4% · INJECTABLE · INJECTION

Approval history

2013-02-28Labeling · Supplement 1AP
2010-06-18Original — Letter ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →